FDA Proposes Revisions to Rules on the Protection of Human Subjects and Cooperative Research
The U.S. Food and Drug Administration (FDA) proposed two new rules that would update regulations 21 CFR 50 (Protection of Human Subjects) and 21 CFR...
Read The Article